We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Real-world outcomes reveal the impact of infusion delays on relapses in a Hispanic cohort, suggesting improved management strategies.
Provide real-world outcomes of Inebilizumab in Hispanic-predominant population.
No takes yet. Share an insight, caveat, or question.
Leal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: